» Articles » PMID: 1754886

Clinical Assessment of Venous Thromboembolic Risk in Surgical Patients

Overview
Publisher Thieme
Date 1991 Jan 1
PMID 1754886
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Prophylaxis against postoperative venous thromboembolism should be tailored according to the patient's level of risk. However, risk assessment is not yet in widespread use in surgical practice. In this study, 538 general surgical patients were prospectively assessed based on a scoring system containing 20 risk factors. Depending on the total risk factor score, the patients were grouped into low (0 to 1, 34.5%), moderate (2 to 4, 48.5%), or high risk (more than 4, 17.2%) categories. Statistically significant (p less than 0.0001) correlation was found between our results and those of three existing risk assessment systems. Overall, of the 538 patients, 37.2% received prophylaxis; 10%, 42.1%, and 76% received prophylaxis in the low-, moderate-, and high-risk categories, respectively. Mechanical prophylactic modalities (graduated elastic compression and sequential intermittent compression) were preferred over pharmacologic modalities. These results suggest that implementation of prophylaxis remains underutilized despite published reports, including NIH guidelines. Our results indicate that the majority of surgical patients seen in this suburban hospital have two or more risk factors for developing venous thromboembolism.

Citing Articles

Preventable Hospital Admission-associated VTE: Thoughts on Thromboprophylaxis as Asians.

D Maran E, Er C, Gohar S, Adamjee T Int J Angiol. 2025; 34(1):78-81.

PMID: 39944141 PMC: 11813597. DOI: 10.1055/s-0044-1791544.


Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study.

Shi X, Zhang Y, Yi F, Dong S, Chen Q, Jiao X Thromb J. 2025; 23(1):11.

PMID: 39924523 PMC: 11809021. DOI: 10.1186/s12959-025-00687-y.


Effect of prophylactic doses of enoxaparin on antifactor Xa activity confirmed by rotational thromboelastometry in critically ill patients: a preliminary prospective cohort study.

Czempik P, Beberok A Front Pharmacol. 2025; 15:1498188.

PMID: 39881863 PMC: 11774899. DOI: 10.3389/fphar.2024.1498188.


Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies.

Vladic N, Englisch C, Ay C, Pabinger I Res Pract Thromb Haemost. 2025; 9(1):102664.

PMID: 39877524 PMC: 11772966. DOI: 10.1016/j.rpth.2024.102664.


Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non-Hodgkin Lymphoma Patients.

Li W, Liu R, Shen Y, Gao G, Yang R, Wang Y Cancer Med. 2024; 13(24):e70510.

PMID: 39711462 PMC: 11664237. DOI: 10.1002/cam4.70510.